Navigation Links
Double in Medical Technology

J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory

... J. Craig Venter Institute (JCVI), was awarded the double Helix Medal from Cold Spring Harbor Laboratory ... event in New York City. Dr. Venter received the double Helix Medal along with Dr. James D. Watson for ... to Dr. Bruce Stillman, CSHL President, "The double Helix Medals recognize individuals who have ...

New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting

... events (AEs) (greater than or equal to 5% and double the rate of placebo in any SEROQUEL XR dose ... events (AEs) (greater than or equal to 5% and double the rate of placebo in any SEROQUEL XR dose ... events (AEs) (greater than or equal to 5% and double the rate of placebo in any SEROQUEL XR dose ...

Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status

... parameters of a single dose of AZ-007. Using a double blind, randomized, dose-escalation trial design, ... was an in-clinic, multi-center, randomized, double blind, single-administration, placebo-controlled ... profile, and has initiated the randomized, double blind, placebo-controlled segment of the ...

Results From Trials of DHA in Alzheimer's Disease and Age-Related Cognitive Decline

... of Neurology at Oregon Health and Sciences University, conducted a double blind, randomized, placebo-controlled clinical trial comparing DHA and ... memory complaints who took algal DHA capsules for six months had almost double the reduction in errors on a test that measures learning and memory ...

New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer

... - Several SSRIs more than double risk of cancer recurrence in tamoxifen treated patients - Nearly 30 ... prescribed to women taking the breast cancer drug tamoxifen more than double the risk of a breast cancer recurrence for those using both medications. ...

Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System

... patients in the right situation." The MitraClip device creates a double orifice mitral valve by securing the leaflets to reduce MR in a replication of the surgical procedure pioneered by Ottavio Alfieri, MD. The resulting double orifice has an inherently smaller cross sectional area compared to the ...

Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease

... in PAH are ongoing and will be announced at a later date. The double blind, placebo-controlled trial presented at ERS enrolled 59 patients with ... for their next dose, in which case the missed dose should not be taken. A double dose should not be taken to make up for any missed dose. (+)Numbers ...

Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain

... suggest that treatment with DCVax(R)- Brain has the potential to more than double the time to tumor recurrence, and more than double survival time for patients suffering from this dreadful disease." GBM, ...

ATHENA Clinical Results with Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress

... drug discontinuation between the 2 study groups. ATHENA, was the largest double blind randomized study in patients with atrial fibrillation, and conducted ... Atrial Fibrillation Foundation expects the number of patients with AF to double in the next 20 years. Without appropriate management, atrial fibrillation ...

ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress

... including congestive heart failure. ATHENA, was the largest double blind randomised study in patients with atrial fibrillation, and conducted ... Atrial Fibrillation Foundation expects the number of patients with AF to double in the next 20 years. Without appropriate management, atrial fibrillation ...

Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation

... treatment option for atrial fibrillation." ATHENA, the largest double blind randomized study in patients with atrial fibrillation, was conducted ... Atrial Fibrillation Foundation expects the number of patients with AF to double in the next 20 years. Without appropriate management, atrial fibrillation ...

Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance

... immuno-compromised conditions and several successful studies including 2 double blind, placebo controlled trials in Division 1 athletes, the Surgex(TM) ... claims, excess protein, stimulants, and banned substances. In double blind placebo controlled trials at the Rutgers University Human ...

RediClinic Offers Affordable New Plan Clinically Shown to Double a Person's Chance to Stop Smoking

... includes, when appropriate, a medication that is clinically shown to double a person's chance of successfully quitting. According to the Centers for ... by RediClinic's nurse practitioners, that is clinically shown to double a person's chances to successfully stop smoking. These results are based ...

Diabetes Gene Raises Odds of Lower Birth Weight

... Struan F.A. Grant, Ph.D., a researcher at the Center for Applied Genomics of The Children's Hospital of Philadelphia. "This gene variant carries a double whammy, in raising the risk of both lower birth weight and the development of type 2 diabetes in later life." Type 2 diabetes occurs either ...

Unlikely Treatment Identified by BrainCells Neurogenesis Platform Improved Clinical Outcomes in Patients Suffering From Depression

... and dosing that shaped the clinical trial protocol, directing the first rational approach to drug development in the area of psychiatry." The double blind, placebo-controlled, randomized study evaluated the efficacy of BCI-952 for the treatment of MDD in 142 patients over a six-week period. ...

R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent

... ------------------- --- --- --- --- Trial Design TASKi3 was a 3 month, multi-center, randomized, double blind, placebo controlled, parallel dose clinical trial involving 219 RA patients in the U.S. who had failed to respond to at least one biologic ...

Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology

... of disease processes related to hypertension, heart disease, kidney failure and cancer. ZFNs are engineered proteins that induce double strand breaks at specific sites in an organism's DNA. Such double-strand breaks stimulate the cell's natural DNA-repair pathways and can result in ...

R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023

... As the next step, single and 5-day repeated applications of RK-023 preparation to the scalp were conducted by a randomized, placebo-controlled, double blind method to evaluate the safety and pharmacokinetics of the drug. In the single-dose study, 2 ml of RK-023 preparation was applied to the vertex ...

BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza

... Under the terms of the agreement, BioCryst may receive future clinical and commercial event milestone payments up to $116 million, as well as double digit royalty payments on product sales of peramivir. BioCryst retains its rights to commercialize peramivir in countries outside of Japan, Taiwan ...

PTSD Associated With Higher Alzheimer's/Dementia Risk; Moderate Alcohol Consumption May Lower it

... demographic groups, focusing on behaviors that modify your risk for developing Alzheimer's disease," Jackson added. PTSD Linked to Nearly double Dementia Risk in Veterans Post-traumatic stress disorder (PTSD) is common among veterans returning from combat and there is some evidence that ...

Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial

... Mean Change -4 -20 -16 Study Design TASKi2 was a 6 month, multi-center, randomized, double blind, placebo controlled, parallel dose clinical trial involving 457 RA patients in the U.S., Latin America and Europe who had failed to respond to ...

Why Do African-Americans Fare Worse With Cancer? Access and Economics Are Only Part of the Story

... - is amplified by another recent study in the Journal of Clinical Oncology . It predicts the cancer incidence among minorities will nearly double in the coming decades, increasing 99% by 2030 compared to an expected 31% increase among whites. And the American Society of Clinical Oncology, ...

HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens

... compliance by a mere 10 percent, Mayberry notes, annual savings should equal about $18 billion. "Over ten years," he pointed out, "that is more than double what the PhRMA program seeks to achieve." The HCPC is a not-for-profit trade association that was formed in 1990 to promote the many benefits of ...

Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease

... Under the terms of the collaboration Shire will pay development and sales milestones up to a maximum of $390 million, and will also pay tiered, double digit royalties on net sales of the products. Shire also shares world-wide development costs on a 50/50 basis, and in return Shire received rights to ...

When It Comes to Natural Remedies for Hormonal Balance, the Proof Is in the Clinical Research

... supports the body's ability to balance (either increase or decrease) levels of its own hormones. Passing stringent pharmacology, toxicology and double blind placebo controlled clinical trials for health and safety, Femmenessence is as safe and side effect-free as your own hormones have been ...

Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk

... the proportion of subjects who lose greater than or equal to 5% of baseline body weight in the active-product group is at least 35%, is approximately double the proportion in the placebo-treated group, and the difference between groups is statistically significant. About Arena Pharmaceuticals ...

PARI Pharma Reports Successful Phase Ib Clinical Results for Inhaled Liposomal Cyclosporine A and Gains FDA Orphan Drug Designation for the Prevention and Treatment of Bronchiolitis Obliterans

... solve this unmet medical need." PARI Pharma's Phase Ib clinical trial for L-CsA studied 12 lung transplant recipients, where five patients had double lung transplants and seven patients had single lung transplants. Patients were given a single dose application of 10mg or 20mg of liposomal L-CsA, ...

Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program

... patients on study was reduced progressively over time. Patients from the placebo cohort in the blinded studies entered this study with approximately double the mean dexamethasone dosing of patients from the prior active treatment cohort. The patient dosing of dexamethasone was reduced sharply once on ...

Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types

... be advised to take their dose as soon as possible unless it is almost time for their next dose, in which case the missed dose should not be taken. A double dose should not be taken to make up for any missed dose. * Numbers indicate the range of percentages in 4 studies among adult patients with Ph+ ...

Study Confirms Effectiveness of Innovative Prism Glasses For Hemianopia Patients

... avoid them without turning their eyes and head. (In earlier designs by other scientists, the prism was in the middle of the lens and caused double vision.) "The best case scenario," says Peli, "is for a patient to be able to make rapid decisions based on the perception rather than moving ...

Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results

... (WHO), the number of people who have diabetes worldwide was approximately 170 million people in 2000, with that number anticipated to more than double by the year 2030.(2) Accounting for about 90 percent of diabetes cases worldwide, type 2 diabetes results from the body's inability to respond ...

D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients

... in healthy volunteers, as well as scale-up and optimization of the DP-b99 manufacturing process. The planned Phase III trial is a randomized, double blind, placebo-controlled study (study acronym MACSI: Membrane Activated Chelator Stroke Intervention). It is designed to compare the effect on ...

No Causality Found Between Black Cohosh and Liver Problems

... Naser, MD, presented at the American College of Obstetricians and Gynecologists Annual Clinical Meeting in Chicago results of a placebo-controlled, double blind study. He concluded that the isopropanolic black cohosh extract (Remifemin(R)) has no effects on liver function. These findings are in ...

Oramed Pharmaceuticals Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin Capsule

... as it will test its first indication for ORMD-0801 on a large group of volunteers for the duration of six weeks. This six week randomized, double blind placebo controlled study will be performed in three locations in Cape Town. The principle investigators of the study will be renowned South ...

Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial

... similar between the treatment arms. The trial was conducted in 40 centres in the United Kingdom, Ireland, Australia and New Zealand. It was a double blind, placebo controlled study designed in consultation with the European Medicines Agency (EMEA) with the objective of seeking a marketing ...

Fovea Reports Positive Results with Prednisporin(TM) in Persistent Allergic Conjunctivitis

... Pataday(TM) (an anti-histamine) had negligible effect on these parameters in this patient population. The prospective, multicenter, randomized, double masked, bilateral comparison study with 150 patients was conducted by Ora Inc., in the USA utilizing Ora's Enviro-CAC(TM) clinical technology. The ...

Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients

... 48-week investigational regimen yielded nearly double SVR rate compared to standard of care Update on next-generation HCV protease inhibitor SCH 900518 presented at EASL annual meeting ...

Genes Identified That Enhance Tumor Cell Sensitivity to CTI's Cancer Drug Brostallicin

... Brostallicin is a small-molecule chemotherapeutic agent with a unique mechanism of action -- it binds to the minor grooves located in the DNA double helix. To identify genes associated with cellular response to brostallicin, a high-throughput RNA interference screen was performed in selected ...

QRxPharma Successfully Completes Comparative Study for Dual-Opioid(TM) Pain Therapy

... QRxPharma. "From these data, we are confident that our upcoming Phase 3 Combination Rule study will prove successful." In this randomized, double blind study of 197 patients at 6 US clinical research sites, MoxDuo(TM) IR was compared to morphine and oxycodone in managing acute pain during the ...

Schering-Plough Announces Results of the Early ACS Trial

... commenced after angiography but pre-PCI. After randomization, patients received double-blinded early eptifibatide (180 mcg/kg intravenous double bolus [10 minutes apart] and 2.0 mcg/kg/min [1.0 mcg/kg/min if creatinine clearance <50 mL/min] infusion), or matching placebo. For bleeding, the ...
Other Contents
(Date:9/30/2014)... your doctor to know what goes wrong with your muscles ... to know what "normal" actually is. That,s where a new ... FASEB Journal comes in. In the ... set of molecules that can help scientists "see" which genes ... more, they found never-before-detected gene activity and that men have ...
(Date:9/30/2014)... 30, 2014  Spectra Automation, a trusted ... biotech and power generation industries, announced today ... Manager, an easy-to-use and cost-effective data collection, ... development laboratories. Most upstream ... analyzer systems. Accessing and consolidating data from ...
(Date:9/30/2014)... of The Economist,s prestigious Innovation awards 2014 will speak ... the JW Marriott Hong Kong on Friday, October 10 th ... and the lessons those hold for others. The awards, which recognises ... decade, will be presented at a ceremony in Hong ... the first time the ceremony has come to Asia ...
Breaking Biology News(10 mins):Scientists identify which genes are active in muscles of men and women 2Spectra Automation Introduces RECONN Bioprocess Manager 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 3Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 4Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 5Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 6Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 7
(Date:10/1/2014)... Farmington Company today announced it ... and visual identity helping brokers, consultants and companies ... to create greater benefit communication synergies. They unveiled ... empowering customers to better leverage Farmington Company’s industry-tested ... of the rebrand is the refreshed tagline: For ...
(Date:10/1/2014)... finding from Duke Medicine suggests that some people who ... be hard-wired to gain weight when exposed to chronic ... estimated 13 percent of people, all of whom are ... could help them reduce heart disease with simple interventions ... , "Genetic susceptibility, psychosocial stress and metabolic factors act ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Between 23 ... in the U.S., according to figures from the National ... Diseases Association (AARDA), and many of them have something ... of having undiagnosed celiac disease. Gluten Free Therapeutics, ... awareness of undiagnosed celiac disease by publishing a series ...
(Date:10/1/2014)... 01, 2014 Diet Doc understands that many ... lose weight and their dieting attempts could be easily sabotaged ... hormone diet treatments into their programs as a ... see fast and effective weight loss results, it also allows ... habits to maintain their weight for the future. , Earlier ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Anti Aging ... and skin rejuvenating destination of choice, is announcing a ... October through to December. , “We’re doing this because ... possible to our top skin clinic in Toronto,” says ... do so much at Anti Aging Clinic, including laser ...
Breaking Medicine News(10 mins):Health News:Farmington Company Launches Rebrand and New Positioning 2Health News:Gene interacts with stress and leads to heart disease in some people 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 4Health News:Anti Aging Clinic, the GTA’s Premier Provider of Anti Aging Treatments, Announces Deal on Units of Botox 2
Other TagsOther Tags